AbbVie <ABBV.N>: Bernstein raises target price to $230 from $225
ABBV•Related News
AstraZeneca investors balk at $400 billion Bristol Myers tie-up reports
AZN•
US Stocks-Wall St futures gain on Mideast deal hopes; healthcare in focus
SPY•
Meat packer Tyson Foods down after cutting annual profit forecast
TSN•
Marriott International's Q2 adj profit beats on fee growth
MAR•
Avista Q2 EPS USD 0.43
AVA•